Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial
Cell Stem Cell · 2024-07 · 31 (7) · 961-973.e8
DOI: 10.1016/j.stem.2024.04.021 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Cell Stem Cell, 2024-07. Verfasst von Shiqi Li und 19 weiteren Autor:innen. Beteiligte Einrichtung: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, Yunnan 650100, China. Hauptthemen laut MEDLINE: beta-Thalassemia, Genetic Therapy, Lentivirus, beta-Globins. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Jiao Tong University, National Key Research and Development Program of China, Science and Technology Innovation Plan Of Shanghai Science and Technology Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, Yunnan 650100, China.
- Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China; BDgene Therapeutics, Shanghai 200240, China.
- Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine…
- BDgene Therapeutics, Shanghai 200240, China.
- Sequanta Technologies, Shanghai 200131, China.
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, Yunnan 650100, China. Electronic address: sanbin1011@163.com.
Förderung
- Shanghai Jiao Tong University
- National Key Research and Development Program of China
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
- National Natural Science Foundation of China
Zitieren
APA
Li, S., Ling, S., Wang, D., Wang, X., Hao, F., Yin, L., Yuan, Z., Liu, L., Zhang, L., Li, Y., Chen, Y., Luo, L., Dai, Y., Zhang, L., Chen, L., Deng, D., Tang, W., Zhang, S., Wang, S., & Cai, Y. (2024). Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial. Cell Stem Cell, 31(7), 961-973.e8. https://doi.org/10.1016/j.stem.2024.04.021
Vancouver
Li S, Ling S, Wang D, Wang X, Hao F, Yin L, et al. Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial. Cell Stem Cell. 2024;31(7):961-973.e8. doi:10.1016/j.stem.2024.04.021
BibTeX
@article{Li2024,
author = {Li, Shiqi and Ling, Sikai and Wang, Dawei and Wang, Xiaoyuan and Hao, Fangyuan and Yin, Liufan and Yuan, Zhongtao and Liu, Lin and Zhang, Lin and Li, Yu and Chen, Yingnian and Luo, Le and Dai, Ying and Zhang, Lihua and Chen, Lvzhe and Deng, Dongjie and Tang, Wei and Zhang, Sujiang and Wang, Sanbin and Cai, Yujia},
title = {Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial},
journal = {Cell Stem Cell},
year = {2024},
volume = {31},
number = {7},
pages = {961--973.e8},
doi = {10.1016/j.stem.2024.04.021}
}
EUVIMED